Summary

4.33 0.23(5.60%)09/13/2024
Waldencast Acquisition Corp (WALD)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 YearsAll Time
5.6011.6056.70-6.62-41.45-42.800.00-83.18


Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1


Trading Data
Close4.33
Open4.14
High4.36
Low4.12
Volume111,650
Change0.23
Change %5.60
Avg Volume (20 Days)633,949
Volume/Avg Volume (20 Days) Ratio0.18
52 Week Range2.41 - 12.00
Price vs 52 Week High-63.92%
Price vs 52 Week Low79.67%
Range-5.76
Gap Up/Down0.03
Fundamentals
Market Capitalization (Mln)534
EBIDTA0
PE Ratio0.0000
PEG Ratio0.0000
WallStreet Target Price0.00
Book Value0.1160
Earnings Per Share0.0000
EPS Estimate Current Quarter0.0000
EPS Estimate Next Quarter0.0000
EPS Estimate Current Year0.0000
EPS Estimate Next Year0.0000
Diluted EPS (TTM)0.0000
Revenues
Profit Marging0.0000
Operating Marging (TTM)0.0000
Return on asset (TTM)0.0000
Return on equity (TTM)-99,999.9900
Revenue TTM0
Revenue per share TTM0.0000
Quarterly Revenue Growth (YOY)0.0000
Quarterly Earnings Growth (YOY)0.0000
Gross Profit (TTM)0
Dividends
Dividend Share0.0000
Dividend Yield
Valuations
Trailing PE0.0000
Forward PE0.0000
Price Sales (TTM)0.0000
Price Book (MRQ)0.0000
Revenue Enterprise Value 0.0000
EBITDA Enterprise Value0.0000
Shares
Shares Outstanding34,500,000
Shares Float34,500,000
Shares Short0
Shares Short (Prior Month)0
Shares Ratio0.00
Short Outstanding (%)0.00
Short Float (%)0.00
Insider (%)0.00
Institutions (%)18.25


09/09 09:37 EST - globenewswire.com
Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate
These New Products are the Latest Innovation to Obagi's ELASTIDERM® Collection These New Products are the Latest Innovation to Obagi's ELASTIDERM® Collection
08/28 14:30 EST - seekingalpha.com
Waldencast plc (WALD) Q2 2024 Earnings Call Transcript
Waldencast plc. (NASDAQ:WALD ) Q2 2024 Earnings Conference Call August 28, 2024 8:30 AM ET Company Participants Allison Malkin - Investor Relations, ICR Michel Brousset - Founder & Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Olivia Tong - Raymond James Linda Bolton Weiser - DA Davidson Dana Telsey - Telsey Advisory Group Operator Greetings.
08/28 12:58 EST - fool.com
Why Waldencast Stock Is Skyrocketing Today
Waldencast posted Q2 sales that came in far above the market's expectations. Comparable sales growth accelerated significantly on a sequential quarterly basis.
08/27 17:26 EST - globenewswire.com
Waldencast Reports Q2 2024 Financial Results
$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023
08/21 06:45 EST - globenewswire.com
Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, provided second quarter and first half fiscal 2024 earnings conference call and webcast information. As previously announced, the Company will report second quarter and first half fiscal 2024 earnings on August 27th, after the close of the U.S. stock market. The Company will conduct a conference call to discuss its earnings results on Wednesday, August 28, 2024 at 8:30am ET.
08/14 11:36 EST - zacks.com
4 Cosmetics Stocks Worth Watching Amid Industry Challenges
The Zacks Cosmetics industry is grappling with elevated inflationary pressures. Coty, Inter Parfums (IPAR), Waldencast (WALD) and Olaplex (OLPX) are capitalizing on digital advancements and innovative strategies.
08/07 16:15 EST - globenewswire.com
Waldencast Announces Participation in the Canaccord Genuity 44th Annual Growth Conference
WHITE PLAINS, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in the Canaccord Genuity 44th Annual Growth Conference being held at the InterContinental Boston Hotel in Boston, Massachusetts.
06/27 17:15 EST - globenewswire.com
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates.
05/30 06:45 EST - globenewswire.com
Waldencast Announces Participation in Upcoming Investor Conferences
WHITE PLAINS, N.Y., May 30, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in upcoming investor conferences.
05/21 06:45 EST - globenewswire.com
Waldencast Reports Q1 2024 Financial Results
$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023
05/13 16:15 EST - globenewswire.com
Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results before the U.S. stock market opens on Tuesday, May 21, 2024. The Company will conduct a conference call to discuss its earnings results on the same day at 8:30am ET.
05/01 16:05 EST - globenewswire.com
Waldencast Announces Participation in CreatorIQ Connect Europe
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, today announced its participation in the CreatorIQ Connect Europe conference, which will be held in London on Thursday, May 2, 2024.
04/30 06:45 EST - globenewswire.com
Waldencast Reports Fiscal Year 2023 Financial Results
2023 Net Revenue of $218.1 millionGroup Combined Comparable Revenue of $212.5 million, a 15.3% increase vs 2022Group Combined Adjusted EBITDA of $24.4 million, up from ($8.8) million in 2022
04/21 18:30 EST - prnewswire.com
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW
NEW YORK , April 21, 2024 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
04/15 11:51 EST - prnewswire.com
TOP RANKED ROSEN LAW FIRM Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW
NEW YORK , April 15, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
04/05 18:45 EST - prnewswire.com
ROSEN,A TOP RANKED LAW FIRM, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW
NEW YORK , April 5, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
03/25 18:57 EST - headlinesoftoday.com
Waldencast Regains Compliance with Nasdaq Filing
WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) — Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that on March 21, 2024 the Company received formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that it has regained compliance with Nasdaq’s filing requirements, as set forth in Nasdaq Listing … The post Waldencast Regains Compliance with Nasdaq Filing appeared first on Headlines of Today...
03/25 17:05 EST - globenewswire.com
Waldencast Regains Compliance with Nasdaq Filing Requirements
WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that on March 21, 2024 the Company received formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that it has regained compliance with Nasdaq's filing requirements, as set forth in Nasdaq Listing Rule 5250(c) (the “Periodic Filing Rule”) following the filing of the Company's financial results for the interim period ended June 30, 2023 with the U.S. Securities and Exchange Commission. In line with the applicable Nasdaq Listing Rules in such circumstances, the notice also indicated that Nasdaq had imposed a “Mandatory Panel Monitor” as that term is defined in Nasdaq Listing Rule 5815(d)(4)(B), for a period of one year from the date of the compliance determination (March 21, 2024), pursuant to which in the event the Company fails to timely satisfy the Periodic Filing Rule during the one-year monitor period, the Company will not have the opportunity to provide a compliance plan for the Nasdaq Listing Qualifications Staff's review; rather, Nasdaq would instead issue a delist determination pursuant to which the Company could request a hearing and stay of the delist determination pending another hearing before the Panel.
03/24 09:30 EST - prnewswire.com
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW
NEW YORK, March 24, 2024 /PRNewswire/ -- WHY:  Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
03/21 09:26 EST - businesswire.com
Johnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws; WALD, WALDW
SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, LLP is investigating whether Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. What if I purchased Waldencast securities? If you purchased secur.